Treatment With Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence: Results of a Randomized Placebo-Controlled Phase III Clinical Trial

NCT00603343 Phase 3 COMPLETED

The study was conducted between 2004 and 2006 to prove efficacy and tolerability of the antimuscarinic propiverine compared to placebo in children suffering from non-neurogenic overactive bladder and urinary incontinence.

Details

Lead sponsor	APOGEPHA Arzneimittel GmbH
Phase	Phase 3
Status	COMPLETED
Enrolment	303
Start date	2004-06
Completion	2006-12

Conditions

• Overactive Bladder
• Urinary Incontinence
• Children

Interventions

• Mictonetten 5 mg, coated tablet
• placebo

Primary outcomes

• voiding frequency — before therapy and at end of therapy